About
Jonathan Dickinson, CEO and co-founder of Ambio Life Sciences and author of Ibogaine and the Bicameral Mind, returns to the Brainforest Café for part two of his conversation with Dr. Dennis McKenna. Where part one followed the personal journey, this one goes into the machinery: what ibogaine is actually doing to the mind and to the cell.
- - -
Jonathan Dickinson, co-founder and CEO of Ambio Life Sciences and
founder of Terragnosis, joins Dr. Dennis McKenna on the Brainforest Café
for a conversation about ibogaine, iboga, and the Bwiti tradition of
Gabon.
A Mexico-licensed psychologist and former executive director of
the Global Ibogaine Therapy Alliance, Jonathan helped develop the
field's foundational safety guidelines and completed the first
Nagoya-compliant export of Tabernanthe iboga root. In part one of a
two-part conversation, he traces the path from harm reduction work in
Vancouver's Downtown Eastside to initiation in Gabon, and explains why
ibogaine refuses to behave like a pharmaceutical. It does not reduce
symptoms. It opens a door, and the person has to walk through it.
Learn more about your ad choices. Visit megaphone.fm/adchoices
- - -
Jonathan Dickinson, co-founder and CEO of Ambio Life Sciences and
founder of Terragnosis, joins Dr. Dennis McKenna on the Brainforest Café
for a conversation about ibogaine, iboga, and the Bwiti tradition of
Gabon.
A Mexico-licensed psychologist and former executive director of
the Global Ibogaine Therapy Alliance, Jonathan helped develop the
field's foundational safety guidelines and completed the first
Nagoya-compliant export of Tabernanthe iboga root. In part one of a
two-part conversation, he traces the path from harm reduction work in
Vancouver's Downtown Eastside to initiation in Gabon, and explains why
ibogaine refuses to behave like a pharmaceutical. It does not reduce
symptoms. It opens a door, and the person has to walk through it.
Learn more about your ad choices. Visit megaphone.fm/adchoices